Mednet Logo
HomeOphthalmology
Ophthalmology

Ophthalmology

Expert insights on ocular conditions, surgical techniques, retinal disease, and vision-related management.

Recent Discussions

Do you utilize thrombolytic therapy in patients with CRAO?

2 Answers

Mednet Member
Mednet Member
Neurology · University of Virginia, School of Medicine

Yes. The previous trial was negative because patients with CRAO were included after 4.5 hours. There are trials underway in Europe for both tPA and TNK to address that. The retina will irreversibly infarct if the blood flow is not restored within 240 minutes (this is from basic science studies with ...

How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

Anterior uveitis has many known causes that include HLA-B27-associated (often with ankylosing spondylitis); viral such as herpes simplex, CMV, or zoster; or as part of a syndrome that includes interstitial nephritis; or as a manifestation of juvenile arthritis. Labeling it acute means that it starts...

Which method do you prefer to assess for stigmata of old optic neuropathy?

1 Answers

Mednet Member
Mednet Member
Neurology · OHSU

If I'm not convinced based on my history and exam, I will typically refer to ophthalmology and at our institution, they tend to gravitate towards OCT rather than VEPs. There are a number of findings on examination to complement the history, including afferent pupillary response to light, errors on i...

Would you consider utilizing a TNF-inhibitor in a patient with RA/SLE overlap who has already tried methotrexate, hydroxychloroquine, and abatacept?

4
4 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

I would not hesitate to use a TNFi in this situation. For my rationale, see a previous post I answered with a similar question that includes the references for my answer: https://www.themednet.org/question/16121. However, as others have answered in this post, alternatives should also be considered.I...

What is your approach to the workup for an underlying systemic condition in a patient presenting with retinal vasculitis?

5
1 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

Retinal vasculitis is a frequently misunderstood condition. My colleagues and I have written about it on several occasions such as in Current Opinion in Rheumatology, 2016. Retinal vasculitis is often diagnosed by an ophthalmologist on the basis of vascular leakage in a test called a fluorescein ang...

How do you manage occlusive bilateral retinal vasculitis with isolated lupus anticoagulant positivity?

4 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

Although I consider myself an expert on retinal vasculitis, I would often solicit help from a physician with expertise in coagulation, especially if that expertise is related specifically to the lupus anticoagulant. A tremendous part of the treatment strategy depends on the location and severity of ...

Is thyrotropin receptor antibody a good biomarker to predict development of thyroid eye disease?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

Patients with thyroid eye disease usually have positive TRAb or TSI but in patients with Graves' hyperthyroidism it does not help predict the development of eye disease which is much less common than hyperthyroidism.

Is it safe to use quinacrine in SLE patients with a history of hydroxychloroquine-associated retinopathy?

2
3 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

To my knowledge, quinacrine, an anti-malarial, is not FDA-approved for use in the US. It may be obtained from compounding pharmacies but the FDA makes no assertions regarding either its safety or its efficacy. For lupus, it has been used primarily as adjunctive therapy for cutaneous disease, e.g. ad...

What is the risk of uveitis flare in patients with JIA and uveitis, who are in remission, when tapering medications?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

The ADJUST Trial is in progress and is trying to answer precisely this question for those currently receiving adalimumab. I am not aware currently of a large database to provide a reliable answer to this question. My approach is to require no evidence for active uveitis for at least 12 months, and t...

What would be your approach to a patient with Scleroderma/Myositis overlap syndrome (+anti-Ku) and active inflammatory eye disease despite high dose mycophenolate?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

This is a challenging question but impossible to answer without more information. Inflammatory eye disease includes uveitis, scleritis, corneal melt, and orbital inflammation. Just as scleroderma itself has a range of manifestations that drive the treatment, the various eye inflammations would requi...